Drug Type AAV based gene therapy |
Synonyms VGN R09b, VGNR09b |
Target |
Mechanism DDC activators(DOPA decarboxylase activators), Gene transference |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Phase 2 | CN | 27 Jun 2024 | |
Aromatic Amino Acid Decarboxylase Deficiency | Phase 1 | - | 01 May 2024 | |
Primary Parkinson's disease | IND Approval | CN | 22 Apr 2024 |